Misidentification of MLL3 and other mutations in cancer due to highly homologous genomic regions. Issue 13 (10th November 2019)

• Record Type: Journal Article
• Authors: Bowler, Timothy G.; Pradhan, Kith; Kong, Yu; Bartenstein, Matthias; Morrone, Kerry A.; Sridharan, Ashwin; Kessel, Rachel M.; Shastri, Aditi; Giricz, Orsi; Bhagat, Tushar D.; Gordon-Mitchell, Shanisha; Rohanizadegan, Mersedeh; Hooda, Lauren; Datt, Ishan; Przychodzen, Bartlomiej P.; Parmar, Simrit; Maqbool, Shahina; Maciejewski, Jaroslaw P.; Steidl, Ulrich; Greally, John M.; Verma, Amit
• Is Part Of: Leukemia & lymphoma. Volume 60:Issue 13(2019)
• Page Start: 3132
• Page End: 3137
• Publication Date: 2019-11-10
• Subjects: MLL3 -- pseudogenes -- AML; Leukemia -- Periodicals; Lymphomas -- Periodicals; 616.99419
• DOI: 10.1080/10428194.2019.1630620
• Languages: English
• ISSNs: 1042-8194

Abstract

Abstract: The MLL3 gene has been shown to be recurrently mutated in many malignancies including in families with acute myeloid leukemia. We demonstrate that many MLL3 variant calls made by exome sequencing are false positives due to misalignment to homologous regions, including a region on chr21, and can only be validated by long-range PCR. Numerous other recurrently mutated genes reported in COSMIC and TCGA databases have pseudogenes and cannot also be validated by conventional short read-based sequencing approaches. Genome-wide identification of pseudogene regions demonstrates that frequency of these homologous regions is increased with sequencing read lengths below 200 bps. To enable identification of poor quality sequencing variants in prospective studies, we generated novel genome-wide maps of regions with poor mappability that can be used in variant calling algorithms. Taken together, our findings reveal that pseudogene regions are a source of false-positive mutations in cancers